An iridium(iii)-based irreversible protein–protein interaction inhibitor of BRD4 as a potent anticancer agent

Hai-Jing Zhong, Lihua Lu, Ka-Ho Leung, Catherine C. L. Wong, Chao Peng, Siu-Cheong Yan, Dik-Lung Ma, Zongwei Cai, Hui-Min David Wang and Chung-Hang Leung

Chem. Sci., 2015, 6, 5400
DOI: 10.1039/C5SC02321A

Discovery of a Copper-Based Mcl-1 Inhibitor as an Effective Antitumor Agent

Xing Lu, Yan-Cheng Liu, Chris Orvig, Hong Liang and Zhen-Feng Chen

J. Med. Chem., 2020, 63, 9154
DOI: 10.1021/acs.jmedchem.9b02047

ADAM Metalloproteinases as Potential Drug Targets

Caterina Camodeca, Doretta Cuffaro, Elisa Nuti and Armando Rossello

CMC, 2019, 26, 2661
DOI: 10.2174/0929867325666180326164104

Contrasting Anticancer Activity of Half-Sandwich Iridium(III) Complexes Bearing Functionally Diverse 2-Phenylpyridine Ligands

Adam J. Millett, Abraha Habtemariam, Isolda Romero-Canelón, Guy J. Clarkson and Peter J. Sadler

Organometallics, 2015, 34, 2683
DOI: 10.1021/acs.organomet.5b00097

Iridium complexes inhibit tumor necrosis factor-α by utilizing light and mixed ligands

Elodie Sauvageot, Pierre Lafite, Eric Duverger, Ronan Marion, Matthieu Hamel, Sylvain Gaillard, Jean-Luc Renaud and Richard Daniellou

Journal of Organometallic Chemistry, 2016, 808, 122
DOI: 10.1016/j.jorganchem.2016.02.001

Cyclometalated iridium(III) luminescent complexes in therapy and phototherapy

Ana Zamora, Gloria Vigueras, Venancio Rodríguez, M. Dolores Santana and José Ruiz

Coordination Chemistry Reviews, 2018, 360, 34
DOI: 10.1016/j.ccr.2018.01.010

Cyclometalated Rhodium(III) Complexes Based on Substituted 2‐Phenylpyridine Ligands: Synthesis, Structures, Photophysics, Electrochemistry, and DNA‐Binding Properties

Haoran Liang, Taotao Hao, Changzhen Yin, Xi Yang, Haiyan Fu, Xueli Zheng, Ruixiang Li, Dan Xiao and Hua Chen

Eur J Inorg Chem, 2017, 2017, 4149
DOI: 10.1002/ejic.201700700

Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation

Marcia L. Moss and Dmitry Minond

Mediators of Inflammation, 2017, 2017, 1
DOI: 10.1155/2017/9673537

Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution

Matteo Calligaris, Doretta Cuffaro, Simone Bonelli, Donatella Pia Spanò, Armando Rossello, Elisa Nuti and Simone Dario Scilabra

Molecules, 2021, 26, 944
DOI: 10.3390/molecules26040944

Recent advances of iridium(III) metallophosphors for health-related applications

Po-Yu Ho, Cheuk-Lam Ho and Wai-Yeung Wong

Coordination Chemistry Reviews, 2020, 413, 213267
DOI: 10.1016/j.ccr.2020.213267

A Rhodium(III)-Based Inhibitor of Lysine-Specific Histone Demethylase 1 as an Epigenetic Modulator in Prostate Cancer Cells

Chao Yang, Wanhe Wang, Jia-Xin Liang, Guodong Li, Kasipandi Vellaisamy, Chun-Yuen Wong, Dik-Lung Ma and Chung-Hang Leung

J. Med. Chem., 2017, 60, 2597
DOI: 10.1021/acs.jmedchem.7b00133

Discovery of β-carboline copper(II) complexes as Mcl-1 inhibitor and in vitro and in vivo activity in cancer models

Xing Lu, Yan-Cheng Liu, Chris Orvig, Hong Liang and Zhen-Feng Chen

European Journal of Medicinal Chemistry, 2019, 181, 111567
DOI: 10.1016/j.ejmech.2019.111567

Inhibition of the p53/hDM2 protein-protein interaction by cyclometallated iridium(III) compounds

Li-Juan Liu, Bingyong He, Jennifer A. Miles, Wanhe Wang, Zhifeng Mao, Weng Ian Che, Jin-Jian Lu, Xiu-Ping Chen, Andrew J. Wilson, Dik-Lung Ma and Chung-Hang Leung

Oncotarget, 2016, 7, 13965
DOI: 10.18632/oncotarget.7369

3-[4-(1H-Indol-3-yl)-1,3-thiazol-2-yl]-1H-pyrrolo[2,3-b]pyridines, Nortopsentin Analogues with Antiproliferative Activity

Barbara Parrino, Anna Carbone, Gloria Di Vita, Cristina Ciancimino, Alessandro Attanzio, Virginia Spanò, Alessandra Montalbano, Paola Barraja, Luisa Tesoriere, Maria Livrea, Patrizia Diana and Girolamo Cirrincione

Marine Drugs, 2015, 13, 1901
DOI: 10.3390/md13041901

Recent developments and strategies for the discovery of TACE inhibitors

Prashant R. Murumkar, Rahul B. Ghuge, Monica Chauhan, Rahul R. Barot, Sharmishtha Sorathiya, Kailash M. Choudhary, Karan D. Joshi and Mange Ram Yadav

Expert Opinion on Drug Discovery, 2020, 15, 779
DOI: 10.1080/17460441.2020.1744559

Labelling proteins and peptides with phosphorescent d6 transition metal complexes

Timothy U. Connell and Paul S. Donnelly

Coordination Chemistry Reviews, 2018, 375, 267
DOI: 10.1016/j.ccr.2017.12.001

Cyclometalated Ir(III)-8-oxychinolin complexes acting as red-colored probes for specific mitochondrial imaging and anticancer drugs

Ting Meng, Qi-Pin Qin, Zi-Lu Chen, Hua-Hong Zou, Kai Wang and Fu-Pei Liang

European Journal of Medicinal Chemistry, 2020, 192, 112192
DOI: 10.1016/j.ejmech.2020.112192

Luminescent Strategies for Label‐Free G‐Quadruplex‐Based Enzyme Activity Sensing

Dik‐Lung Ma, Zhen‐Zhen Dong, Kasipandi Vellaisamy, Ka‐Man Cheung, Guanjun Yang and Chung‐Hang Leung

The Chemical Record, 2017, 17, 1135
DOI: 10.1002/tcr.201700014

Correlation between the Stereochemistry and Bioactivity in Octahedral Rhodium Prolinato Complexes

Rajathees Rajaratnam, Elisabeth K. Martin, Markus Dörr, Klaus Harms, Angela Casini and Eric Meggers

Inorg. Chem., 2015, 54, 8111
DOI: 10.1021/acs.inorgchem.5b01349

Identification of an iridium(III) complex with anti-bacterial and anti-cancer activity

Lihua Lu, Li-Juan Liu, Wei-chieh Chao, Hai-Jing Zhong, Modi Wang, Xiu-Ping Chen, Jin-Jian Lu, Ruei-nian Li, Dik-Lung Ma and Chung-Hang Leung

Sci Rep, 2015, 5
DOI: 10.1038/srep14544

Iridium(III) complexes as novel theranostic small molecules for medical diagnostics, precise imaging at a single cell level and targeted anticancer therapy

Patryk Szymaszek, Małgorzata Tyszka-Czochara and Joanna Ortyl

European Journal of Medicinal Chemistry, 2024, 276, 116648
DOI: 10.1016/j.ejmech.2024.116648

Mitochondria-localizing curcumin-cryptolepine Zn(II) complexes and their antitumor activity

Li-Qin Qin, Chun-Jie Liang, Zhen Zhou, Qi-Pin Qin, Zu-Zhuang Wei, Ming-Xiong Tan and Hong Liang

Bioorganic & Medicinal Chemistry, 2021, 30, 115948
DOI: 10.1016/j.bmc.2020.115948

An Iridium(III) Complex Inhibits JMJD2 Activities and Acts as a Potential Epigenetic Modulator

Li-Juan Liu, Lihua Lu, Hai-Jing Zhong, Bingyong He, Daniel W. J. Kwong, Dik-Lung Ma and Chung-Hang Leung

J. Med. Chem., 2015, 58, 6697
DOI: 10.1021/acs.jmedchem.5b00375